Challenges and opportunities in spinal muscular atrophy therapeutics.
Yeo CJJ, Tizzano EF, Darras BT.
Lancet Neurol. 2024 Feb;23(2):205-218. doi: 10.1016/S1474-4422(23)00419-2.
Spinal muscular atrophy.
D'Amico A, Mercuri E, Tiziano FD, Bertini E.
Orphanet J Rare Dis. 2011 Nov 2;6:71. doi: 10.1186/1750-1172-6-71.
Adult-onset spinal muscular atrophy: An update.
Juntas Morales R, Pageot N, Taieb G, Camu W.
Rev Neurol (Paris). 2017 May;173(5):308-319. doi: 10.1016/j.neurol.2017.03.015. Epub 2017 Apr 26.
Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review.
Pinto WBVR, Souza PVS, Badia BML, Farias IB, Albuquerque Filho JMV, Gonçalves EA, Machado RIL, Oliveira ASB.
Arq Neuropsiquiatr. 2021 Oct;79(10):912-923. doi: 10.1590/0004-282X-ANP-2020-0429.
Progressive Muscular Atrophy.
Liewluck T, Saperstein DS.
Neurol Clin. 2015 Nov;33(4):761-73. doi: 10.1016/j.ncl.2015.07.005.
Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care.
Schorling DC, Pechmann A, Kirschner J.
J Neuromuscul Dis. 2020;7(1):1-13. doi: 10.3233/JND-190424.
[Adult Spinal Muscular Atrophy].
Walter MC, Hiebeler M.
Fortschr Neurol Psychiatr. 2022 Sep;90(9):421-430. doi: 10.1055/a-1801-3785. Epub 2022 Sep 14.
Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures.
Aponte Ribero V, Martí Y, Batson S, Mitchell S, Gorni K, Gusset N, Oskoui M, Servais L, Sutherland CS.
Neurology. 2023 Nov 21;101(21):e2103-e2113. doi: 10.1212/WNL.0000000000207878. Epub 2023 Oct 9.
Spinal Muscular Atrophy: Family and Provider Perspectives.
Harries M, Alcocer Alkureishi L, Hageman JR.
Pediatr Ann. 2022 Nov;51(11):e409-e410. doi: 10.3928/19382359-20221010-01. Epub 2022 Nov 1.
Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
Finsterer J, Soraru G.
J Mol Neurosci. 2016 Mar;58(3):321-9. doi: 10.1007/s12031-015-0663-x. Epub 2015 Oct 19.
